CAPTRUST Financial Advisors’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $398K | Sell |
7,650
-773
| -9% | -$40.3K | ﹤0.01% | 1873 |
|
|
2025
Q1 | $509K | Sell |
8,423
-1,139
| -12% | -$68.8K | ﹤0.01% | 1632 |
|
|
2024
Q4 | $654K | Buy |
9,562
+3,311
| +53% | +$227K | ﹤0.01% | 1465 |
|
|
2024
Q3 | $450K | Buy |
6,251
+1,164
| +23% | +$83.7K | ﹤0.01% | 1629 |
|
|
2024
Q2 | $353K | Buy |
5,087
+252
| +5% | +$17.5K | ﹤0.01% | 1711 |
|
|
2024
Q1 | $387K | Sell |
4,835
-1,315
| -21% | -$105K | ﹤0.01% | 1630 |
|
|
2023
Q4 | $673K | Buy |
6,150
+1,985
| +48% | +$217K | ﹤0.01% | 1524 |
|
|
2023
Q3 | $420K | Buy |
4,165
+2,175
| +109% | +$219K | ﹤0.01% | 1761 |
|
|
2023
Q2 | $270K | Buy |
+1,990
| New | +$270K | ﹤0.01% | 2051 |
|
|
2022
Q3 | – | Sell |
-1,800
| Closed | -$173K | – | 2437 |
|
|
2022
Q2 | $173K | Buy |
1,800
+52
| +3% | +$5K | ﹤0.01% | 1796 |
|
|
2022
Q1 | $260K | Buy |
1,748
+859
| +97% | +$128K | ﹤0.01% | 1539 |
|
|
2021
Q4 | $126K | Sell |
889
-344
| -28% | -$48.8K | ﹤0.01% | 1972 |
|
|
2021
Q3 | $162K | Buy |
1,233
+45
| +4% | +$5.91K | ﹤0.01% | 1717 |
|
|
2021
Q2 | $164K | Sell |
1,188
-29
| -2% | -$4K | ﹤0.01% | 1654 |
|
|
2021
Q1 | $159K | Buy |
1,217
+967
| +387% | +$126K | ﹤0.01% | 1637 |
|
|
2020
Q4 | $28K | Buy |
250
+75
| +43% | +$8.4K | ﹤0.01% | 2097 |
|
|
2020
Q3 | $14K | Buy |
+175
| New | +$14K | ﹤0.01% | 2134 |
|